Safety and Efficacy of 4-Factor Prothrombin Complex Concentrate: A Retrospective Review of Outcomes at an Academic Hospital

被引：0
|
作者：
Jalaba, Stephanie [1 ]
Benson, Hollie [1 ]
Zhang, Nan [1 ]
Adamski, Jill [1 ]
Kinard, Theresa [1 ]
机构：
[1] Mayo Clin Arizona, Phoenix, AZ USA
来源：
TRANSFUSION | 2017年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C70-A03L
引用
收藏
页码：52A / 52A
页数：1
相关论文
共 50 条
  • [21] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [22] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Troyer, Camille
    Nguyen, Wesley
    Xie, Annie
    Wimer, Dexter
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (01) : 149 - 155
  • [23] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Camille Troyer
    Wesley Nguyen
    Annie Xie
    Dexter Wimer
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 149 - 155
  • [24] EVALUATION OF 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE DOSING FOR FACTOR XA INHIBITOR REVERSAL
    Craven, Cody
    Sbertoli, Robert
    Ramiro, Joanna
    Emery, Darrick
    Braun, James
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 436 - 436
  • [25] IMPACT OF OBESITY ON RESPONSE TO 3-FACTOR AND 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE
    Smetana, Keaton
    Erdman, Michael
    Mohrien, Kerry
    Jones, G. Morgan
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 259 - 259
  • [26] Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate
    Peksa, Gary D.
    Mokszycki, Robert K.
    Rech, Megan A.
    Maynard, Brian
    Panos, Nicholas G.
    Sweis, Rolla T.
    DeMott, Joshua M.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 207 - 215
  • [27] PERIOPERATIVE 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE VERSUS FACTOR VITA IN LIVER TRANSPLANTATION
    Shakowski, Courtney
    Detry, Jason
    MacLaren, Robert
    Lyda, Clark
    Kiser, Tyree
    Mandell, Susan
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [28] Safety and Efficacy of 4-Factor Prothrombin Complex Concentrate in Patients Receiving Vitamin K Antagonists Compared to Patients not Receiving Vitamin K Antagonists: A Single Center Retrospective Review.
    Vakayil, V.
    Coler, E.
    Larson, J.
    Chandrashekar, M.
    Lord, A.
    Welbig, J.
    Zantek, N. D.
    Harmon, J. V.
    ANESTHESIA AND ANALGESIA, 2017, 125 : 3 - 4
  • [29] Discussion of "Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa"
    Van Dusen, Rachel
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 780 - 781
  • [30] Effect of pharmacy management on turnaround time of 4-factor prothrombin complex concentrate
    Langstraat, Eileen
    Martinelli, Ashley
    Spoelhof, Brian
    Shah, Shailly
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (17) : S61 - S66
12345